0001209191-21-065312.txt : 20211117 0001209191-21-065312.hdr.sgml : 20211117 20211117200033 ACCESSION NUMBER: 0001209191-21-065312 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211115 FILED AS OF DATE: 20211117 DATE AS OF CHANGE: 20211117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PISKEL KYLE CENTRAL INDEX KEY: 0001780662 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38957 FILM NUMBER: 211422227 MAIL ADDRESS: STREET 1: C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION STREET 2: 1551 EASTLAKE AVE E STE 200 CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp CENTRAL INDEX KEY: 0001478320 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270907024 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1165 EASTLAKE AVE E CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-659-0067 MAIL ADDRESS: STREET 1: 1165 EASTLAKE AVE E CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: Adaptive TCR Corp DATE OF NAME CHANGE: 20091209 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-15 0 0001478320 Adaptive Biotechnologies Corp ADPT 0001780662 PISKEL KYLE C/O ADAPTIVE BIOTECHNOLOGIES CORP. 1165 EASTLAKE AVE E SEATTLE WA 98109 0 1 0 0 Principal Accounting Officer Common Stock 2021-11-15 4 A 0 3837 0.00 A 6699 D Stock Option (Right to Buy) 32.58 2021-11-15 4 A 0 9592 0.00 A 2031-11-15 Common Stock 9592 9592 D The option will vest with respect to 1/4 of such shares on November 15, 2022, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. /s/ Kyle Piskel by Eric Billings, attorney-in-fact 2021-11-17